Navigation Links
Pandesa ShareVault Enables Secure, Real-time Due Diligence for Biopharmaceutical Partnering

Limerick BioPharma and Cortex Pharmaceuticals Use Industry Leading Virtual Data Room To Share Due Diligence Documents

Los Gatos, CA (PRWEB) September 16, 2009 -- Pandesa, a leading provider of next generation virtual data rooms, has been adopted by a number of pharmaceutical, biopharmaceutical and biotech research and development companies worldwide, to securely share sensitive documents during the due diligence process associated with partnering, licensing, fundraising, mergers and acquisitions, and other business processes.

Pandesa has leveraged its expertise enabling due diligence for top institutions in the financial services industry to develop solutions for a range of markets and business transaction scenarios, including biopharmaceutical partnering. AcelRx Pharmaceuticals, Cortex Pharmaceuticals, DURECT Corporation, Jazz Pharmaceuticals, Limerick BioPharma, XenoPort and dozens of other firms in the industry have selected ShareVault™ for a variety of due diligence applications.

Today's pharmaceutical market is increasingly competitive. To maintain a competitive edge, companies must be able to move quickly to identify, evaluate, and negotiate deals. In order to do so, extensive information is required, including highly sensitive information from clinical trials and research. ShareVault™ provides customers unparalleled features to enable a competitive edge, with an easy to use platform that is fast, secure and reliable.

"A pharmaceutical company's greatest asset is its data. It serves as the foundation for all of our partnering and fund raising efforts. Real-time access to key data from clinical trials and other research greatly facilitates the due diligence process," said Nigel Ray, Vice President of Business Development, Limerick BioPharma, a company that develops compounds to significantly improve drug side effect profiles and clinical outcomes. "ShareVault gives us the ability to move fast and share information, without fearing security risks. With this capability, we're able to conduct deals faster while casting a broader net to get more potential partners."

Pandesa ShareVault™ for biopharmaceutical partnering includes the following features:

  • High, speed encrypted connection;
  • PDF streaming, which enables large documents to open instantly;
  • "Drag and Drop" file indexing, PDF conversion and upload capabilities;
  • Customizable access control and policy-based security features;
  • Detailed activity tracking and reporting;
  • Full-text search;
  • Visual content browsing;
  • In-place editing of tags and permissions; and
  • 24/7 customer support.

ShareVault™ additionally enables multiple companies in different geographic locations to conduct due diligence, reducing the need to coordinate in-person meetings during the each stage of partnering discussions.

"ShareVault's focus on speed helps us accelerate the due diligence process," said Mark Varney, CEO, Cortex Pharmaceuticals, a neuroscience company focused on developing novel AMPAKINE® drug therapies for neurological and psychiatric disorders. "Some of our clinical trial results documents contain thousands of pages, yet our users can open them instantly from ShareVault."

Pandesa ShareVault™ has helped hundreds of companies share mission-critical information in a secure and reliable on-demand environment. Its rapidly growing customer base among biopharmaceutical companies is proof that ShareVault™ is taking virtual data room capabilities to the next level.

"It's gratifying to see ShareVault™ being used so effectively in so many diverse applications. Our customers are realizing that a virtual data room of this caliber saves time and money and ends up making better deals and partnerships," said John Badger, Vice President of Marketing and Product Management, Pandesa.

About Pandesa:
Pandesa Corporation develops and markets ShareVault™, the next generation virtual data room for secure online sharing of sensitive documents during due diligence and other critical business processes. The company was founded in 2003 to help professionals securely share unstructured information in order to facilitate business transactions. Pandesa provides an on demand platform that enables its customers to manage critical time-sensitive and document-centric processes, such as due diligence, where documents must be organized and made available to multiple parties efficiently and securely. Pandesa is based in Los Gatos, California, with development offices in Bangalore, India. For more information, visit:


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Varian Medical Systems Receives FDA 510(k) Clearance for High-Definition Collimator That Enables Ultra-Fine Intensity-Modulated Radiosurgery
2. Biomatricas PCRboost(TM) Enables 5-Fold Improvement in Amplification of Difficult Samples
3. Nektars PEGylation Technology Enables Peptide Mimetic, Highlighted by Data Presented at 45th ERA-EDTA Congress
4. New VeriEye SDK from Neurotechnology Enables Development of Reliable, Cost-effective Biometric Iris Recognition Systems
5. Energetiqs Laser-Driven Light Source Technology Enables Continuous Spectrum Light Sources, from Visible to Deep Ultraviolet
6. Studies Show USGI Medicals EndoSurgical Operating System(TM) Enables Incisionless Surgery to Reduce Gastric Pouch and Stoma After Gastric Bypass
7. Autonomy Meridio Enables Extract Technology to Enhance Capabilities in Compliance With Manufacturing Regulations
8. New kind of MRI enables study of magnets for computer memory
9. PQRI Made Easy(TM): A New Software Enables Healthcare Professionals to Earn Their 2008 and 2009 PQRI Bonuses for Free
10. GridGain 2.1 - Open Cloud Platform Enables Development of Native Cloud Applications
11. Vineland Enables Industries Efforts to Build Agri-Science Research Cluster
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... In harsh ... Insertion points for in-line sensors can represent a weak spot where leaking process ... series of retractable sensor housings , which are designed to tolerate extreme process ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... OrthoAccel® Technologies, Inc., on being named to Deloitte's 2015 Technology Fast 500 list ... facility, OrthoAccel manufactures AcceleDent®, a FDA-cleared, Class II medical device that speeds up ...
(Date:11/24/2015)... ANGELES , Nov. 24, 2015 ... biotechnology company focused on the discovery, development and commercialization ... , Ph.D., Chief Executive Officer, is scheduled to present ... 1, 2015 at 10:50 a.m. EST, at The Lotte ... City . . ...
(Date:11/24/2015)... 24, 2015  PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ... company,s president and chief executive officer, will present at the ... in New York City . The presentation ... 1, 2015 at 9:30 a.m. EST. ... website at least 15 minutes prior to the presentation to ...
Breaking Biology Technology:
(Date:11/17/2015)... PARIS , November 17, 2015 ... November 2015.   --> Paris from ... --> DERMALOG, the biometrics innovation leader, has invented the ... and fingerprints on the same scanning surface. Until now two ... fingerprints. Now one scanner can capture both on the same ...
(Date:11/17/2015)... Nov. 17, 2015  Vigilant Solutions announces today that ... Board of Directors. --> ... retiring from the partnership at TPG Capital, one of ... over $140 Billion in revenue.  He founded and led ... the TPG companies, from 1997 to 2013.  In his ...
(Date:11/16/2015)... , Nov 16, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced expansion of its TDDI ... touch controller and display driver integration (TDDI) ... smartphones. These new TDDI products add to the ... resolution), TD4302 (WQHD resolution), and TD4322 (FHD resolution) ...
Breaking Biology News(10 mins):